Marck Biosciences is set to introduce Paracetamol IV in plastic package, which is manufactured by using Blow-Fill-Seal (BFS) technology, under Febramol IV brand name in India.
Bosch signed agreements to acquire Hüttlin GmbH and Manesty Ltd., subsidiaries of OYSTAR Holding GmbH. The two companies develop, manufacture, and sell process equipment for the pharmaceuticals industry. Hüttlin, based in Schopfheim, Germany, produces specialist drying and granulation equipment, from powder to the production of pharmaceuticals.
YORK Label and the Europe based Pago Group have entered into a definitive agreement to form a global partnership focusing on international customer expansion and support, innovation and technology exchange and operational and efficiency benchmarking.
Althea Technologies, Inc. announced that it has extended its service offering to include labeling, packaging, storage and distribution of drug and biological products through its co-marketing partner, Sherpa Clinical Packaging. Sherpa, founded in 2011, is located adjacent to the Althea’s clinical and commercial-scale biologics and drug product manufacturing facilities. The proximity of the facilities to one another simplifies supply chain logistics for clients of each organization. Additionally, the co-marketing agreement will provide Althea’s clients developing complex biologics products the option of producing, labeling and packaging of drug and biological products during a single campaign.
This new facility is designed around state-of-the-art 1000 sqm class 8 clean room fully compliant with cGMP standards. Rexam Pharma meets the most stringent regulated market requirements and brings to India new technologies such as child-resistant closures and its internationally renowned Rispharm range for ophthalmology.